Literature DB >> 3045146

Immunopathologic studies of cutaneous lupus erythematosus.

T T Provost1, M Reichlin.   

Abstract

The studies, as outlined above, strongly suggest that there may be several pathophysiologic mechanisms resulting in the development of cutaneous lupus lesions. It appears that all lupus lesions are associated predominantly with a T-cell infiltrate. Based upon the studies of the neonatal lupus infants, it has been hypothesized that the U1RNP and Ro(SS-A) autoantibodies of maternal origin play a direct pathologic role in the genesis of the annular polycyclic SCLE lesions and this may be mediated by antibody-dependent cellular cytotoxicity mechanisms in which the antibody binds to the respective antigen present on the keratinocyte plasma membrane and the effector cells are T cells derived from the infants. Other studies, using direct immunofluorescence techniques, have demonstrated an association of cutaneous lupus lesions occurring in the presence of immunoglobulin and complement at the dermal/epidermal junction (positive lupus band test) in which the neoantigen of the complement membrane attack complex (C5b-C9) is detected. These data have been interpreted as indicating that immunoglobulin and complement, perhaps in the form of immune complexes, may play a role in the pathogenesis of some cutaneous lupus lesions. Additional studies have determined that there is a substantial number of lupus patients with cutaneous disease, without antinuclear antibodies, who fail to demonstrate the deposition of immunoglobulin and complement at the dermal/epidermal junction. Furthermore, other studies have indicated that ultraviolet light is capable of inducing lesions in lupus patients that histologically are identical to those of cutaneous lupus erythematosus but that failed to demonstrate the deposition of the immunoglobulin and complement components. Since discoid lupus lesions demonstrate a preponderance of T cells, it has been proposed that some of these lesions are the direct result of a T-cell cytotoxic event. However, the nature of the autoantigens responsible for this putative T cell-mediated cytotoxic response is unknown at the present time. The role of ultraviolet light in the genesis of the cutaneous lupus lesions appears to involve, within the epidermis, the generation of autoantigen macromolecules which then react with autoantibodies or specific T cells of the lupus host.

Entities:  

Mesh:

Year:  1988        PMID: 3045146     DOI: 10.1007/BF00916550

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  58 in total

1.  B-lymphocyte alloantigens associated with systemic lupus erythematosus.

Authors:  J L Reinertsen; J H Klippel; A H Johnson; A D Steinberg; J L Decker; D L Mann
Journal:  N Engl J Med       Date:  1978-09-07       Impact factor: 91.245

2.  Experimental skin lesions in mice resembling systemic lupus erythematosus.

Authors:  P G Natali; E M Tan
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

3.  Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies.

Authors:  T T Provost; F C Arnett; M Reichlin
Journal:  Arthritis Rheum       Date:  1983-10

4.  Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus.

Authors:  R D Sontheimer; P Stastny; J N Gilliam
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

5.  An animal model of antibody binding in cutaneous lupus.

Authors:  L A Lee; W L Weston; G G Krueger; M Emam; M Reichlin; J O Stevens; S K Surbrugg; A Vasil; D A Norris
Journal:  Arthritis Rheum       Date:  1986-06

6.  Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome.

Authors:  H L Franco; W L Weston; C Peebles; S L Forstot; P Phanuphak
Journal:  J Am Acad Dermatol       Date:  1981-01       Impact factor: 11.527

7.  Serological findings in patients with "ANA-negative" systemic lupus erythematosus.

Authors:  P J Maddison; T T Provost; M Reichlin
Journal:  Medicine (Baltimore)       Date:  1981-03       Impact factor: 1.889

8.  Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.

Authors:  M C Hochberg; R E Boyd; J M Ahearn; F C Arnett; W B Bias; T T Provost; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

9.  Lupus band test in untreated SLE patients: correlation of immunoglobulin deposition in the skin of the extensor forearm with clinical renal disease and serological abnormalities.

Authors:  T T Provost; G Andres; P J Maddison; M Reichlin
Journal:  J Invest Dermatol       Date:  1980-06       Impact factor: 8.551

10.  Molecular characteristics of SS-B/La and SS-A/Ro cellular antigens.

Authors:  J S Deng; R D Sontheimer; J N Gilliam
Journal:  J Invest Dermatol       Date:  1985-02       Impact factor: 8.551

View more
  5 in total

Review 1.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 2.  Stress (heat shock) proteins and rheumatic disease. New advance or just another band wagon?

Authors:  N P Hurst
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.

Authors:  Ray-Chang Wu; Jun Qin; Yoshihiro Hashimoto; Jiemin Wong; Jianming Xu; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

4.  Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen.

Authors:  E K Chan; J C Hamel; J P Buyon; E M Tan
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

5.  Direct immunofluorescence in Behçet's disease: a controlled study with 108 cases.

Authors:  Afet Akdag Kose
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.